APEX Biologix Expands its Footprint Through Investment by Desert Highlands Regenerative Merger enables an increased focus on product innovation, more cutting-edge regenerative medicine research and strategic collaborations with other complementary technology companies. News provided by Share this article Share this article SALT LAKE CITY, April 16, 2021 /PRNewswire/ -- Desert Highlands Regenerative (DHR), a private equity group, has acquired a majority ownership of APEX Biologix (APEX), the designers and manufacturers of the XCELL Platelet-Rich Plasma (PRP) and other regenerative medicine pr...